Fig 1: The Nmnat siRNA pools are specific for their intended targets.(A) Each Nmnat siRNA pool specifically blocks expression of a FLAG-tagged version of its intended target in transfected HEK 293T cells. Representative FLAG immunoblot of cells 24 h after co-transfection with expression vectors for each FLAG-Nmnat isoform together with a non-targeting pool of siRNA (siControl) or one of the siNmnat siRNA pools as indicated. Quantification of band intensities relative to bands in the siControl lane in three independent experiments is shown on the right (error bars = ±S.E.M.). Each siRNA pool specifically and significantly reduces expression of its target (***p<0.001, t test of respective siNmnat versus siControl). Each FLAG-Nmnat acts as internal control of transfection efficiency for the others. Only 3/4 of the pooled Nmnat2 siRNAs and 2/4 of the pooled Nmnat3 siRNAs target sequences in the respective expression vectors (compared to 4/4 for the Nmnat1 siRNA pool). All should target the endogenous mRNAs. (B) Each Nmnat siRNA pool specifically blocks expression of a FLAG-tagged version of its intended target in injected SCG neurons. Representative fluorescent images of SCG neurons 48 h after co-injection with one FLAG-Nmnat expression vector, pEGFP-C1, and the relevant siNmnat pool or non-targeting siRNA pool (siControl). eGFP fluorescence identifies injected neurons, FLAG immunostaining shows expression levels of each FLAG-Nmnat, and DAPI labels nuclei. Each siNmnat siRNA pool significantly reduces expression of its target isoform compared to siControl as indicated on the right by quantification of FLAG immunostaining relative to eGFP fluorescence in individual neurons (**p<0.01, ***p<0.001, t test of respective siNmnat versus siControl). Data are from three independent experiments in which at total of 36–55 injected neurons were analyzed (error bars = ±S.E.M.) Localization of each tagged isoform is consistent with their expected distribution; Nmnat1 in nuclei and Nmnat2 and Nmnat3 in cytoplasmic compartments.
Fig 2: Effects of NMNAT2 knockdown on oocyte maturation. (a) The efficiency of NMNAT2 knockdown was verified by Western blot. (b,c) Quantitative analysis of GVBD and Pb1 extrusion in control (n = 114) and NMNAT2‐KD (n = 120) oocytes. (d) Phase‐contrast images of NMNAT2‐KD and control oocytes. Arrow points to oocytes that fail to extrude a polar body and arrowhead denotes the oocytes with symmetrical division. (e) Quantitative analysis of NAD+ content in control (n = 150) and NMNAT2‐KD (n = 150) oocytes. (f) Representative images of CM‐H2DCFDA fluorescence (green) in control and NMNAT2‐KD oocytes. (g) Quantification of ROS signals in oocytes. Values are presented as individual dot plot, n = 15 for each group, biologically independent oocytes from at least two different cultures. (h) Histogram showing the ATP levels in control, NMNAT2‐KD oocytes (n = 60 for each group). Data are expressed as mean ± SD from three independent experiments. *p < 0.05 versus controls. Scale bars: 50 µm
Fig 3: Labelling of NAD salvage pathway machinery in human retina. A NAMPT labelling is detected across all retinal layers, localizing to both nuclear (haematoxylin + ve) and cytoplasmic (haematoxylin −ve) cellular compartments, with the most intense labeling in the INL (n = 11 eyes). B NMNAT1 labelling is strongest in nuclear layers (GCL, INL, ONL) localizing to nuclei (n = 11 eyes). C NMNAT2 labelling localized to cytoplasmic compartments and was detected across all retinal layers, with the greatest intensity in the GCL, reflecting high expression in RGCs (n = 11 eyes). D In the ONH, NAMPT followed the same trend as in the retina, with labelling localizing to both nuclear and cytoplasmic compartments. Labeling intensity did not vary along the length of the optic nerve (n = 11 eyes). E NMNAT1 again localized only to nuclei in the ONH (glial framework), and its intensity was consistent along the length of the optic nerve (n = 10 eyes). F NMNAT2 conversely, localized only to the axonal compartments of the optic nerve and was significantly greater in the first 500 µm of the ONH (n = 8 eyes), potentially reflecting the density of axons relative to glial framework here, or the need for more NMNAT2 at a critical metabolic portion of the axons. N.B. these data do not allow for direct comparison of abundances of these enzymes given the nature of antibody labelling (efficiency and concentration of the antibodies etc.). RNFL retinal nerve fiber layer, GCL ganglion cell layer, IPL inner plexiform layer, INL inner nuclear layer, OPL outer plexiform layer, ONL outer nuclear layer, PS photoreceptor segments. Scale bars = 50 µm in A–C, 500 µm in D–E (overview images) and 50 µm in D–E (inset images)
Fig 4: Effects of BaP treatment on bleb formation and NMNAT2 expression in nerve fibers. After culturing for 3 days, the effects of the direct interaction between hiPSC-SN and BaP were assessed. (a) Morphological changes in nerve fibers 24 h after treatment with BaP. The arrows indicate blebs. (b) Number of blebs at various concentrations of BaP. (c) Double labelling of NMNAT2 (red) and βIII-tubulin (green) in nerve fibers at various concentrations of BaP. (d) NMNAT2-immunoreactive (ir) nerve fiber length normalised to βIII-tubulin-ir nerve fiber length in identical areas at various concentrations of BaP. *** p < 0.001, vs. absence of BaP (Dunnett’s test). Each value represents the mean ± standard deviation of the three wells. BaP: benzo[a]pyrene; NMNAT2: nicotinamide mononucleotide adenylyltransferase 2.
Fig 5: Effects of PE treatment on bleb formation and NMNAT2 expression in nerve fibers. After culturing for 3 days, the effects of the direct interaction between hiPSC-SN and PE were assessed. (a) Morphological changes in nerve fibers 24 h after treatment with PE. The arrows indicate blebs. (b) Number of blebs at various concentrations of PE. *** p < 0.001, vs. absence of PE (Dunnett’s test). (c) Double labelling of NMNAT2 (red) and βIII-tubulin (green) in nerve fibers at various concentrations of PE. (d) NMNAT2-immunoreactive (ir) nerve fiber length normalised to βIII-tubulin-ir nerve fiber length in identical areas at various concentrations of PE. * p < 0.05 vs. absence of PE (Steel’s test). All values represent the mean ± standard deviation of more than three wells. NMNAT2: nicotinamide mononucleotide adenylyltransferase 2; PE: phenoxyethanol.
Supplier Page from Abcam for Anti-NMNAT2 antibody [2E4]